InspireMD, Inc. (NSPR)
NASDAQ: NSPR · IEX Real-Time Price · USD
2.360
-0.030 (-1.26%)
At close: Jul 19, 2024, 4:00 PM
2.385
+0.025 (1.06%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

InspireMD Revenue

InspireMD had revenue of $6.48M in the twelve months ending March 31, 2024, with 23.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.51M with 21.95% year-over-year growth. In the year 2023, InspireMD had annual revenue of $6.21M with 20.00% growth.

Revenue (ttm)
$6.48M
Revenue Growth
+23.91%
P/S Ratio
9.09
Revenue / Employee
$98,136
Employees
66
Market Cap
58.91M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.21M1.03M20.00%
Dec 31, 20225.17M676.00K15.04%
Dec 31, 20214.50M2.01M80.89%
Dec 31, 20202.49M-1.24M-33.22%
Dec 31, 20193.72M120.00K3.33%
Dec 31, 20183.60M840.00K30.42%
Dec 31, 20172.76M867.00K45.78%
Dec 31, 20161.89M-416.00K-18.01%
Dec 31, 20152.31M-508.00K-18.03%
Dec 31, 20142.82M-2.06M-42.17%
Jun 30, 20134.87M-476.00K-8.90%
Jun 30, 20125.35M-655.00K-10.91%
Dec 31, 20116.00M1.06M21.32%
Dec 31, 20104.95M1.54M45.09%
Dec 31, 20093.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 86.62M
HOOKIPA Pharma 53.55M
Cryo-Cell International 31.64M
ProPhase Labs 28.72M
Enzo Biochem 4.72M
VolitionRx 797.03K
Revenue Rankings